Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 01:38:52 - browse：11489

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Biotech stock slump in 2023: awaiting the turnaround

explore

focus

WSS

Readout LOUD podcast: possible new ALS drug, artificial wombs

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Intarcia’s device

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Lifetime voting ban for felony convictions struck down in Mississippi

Medical student insurance fails on mental health care coverage

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

The high cost of giving birth even with insurance

Climate activists disrupt London Pride march to protest corporate sponsorship

Jerome Adams on the need for new antivirals for Covid

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

New air purifier tech could be key to improving indoor air quality

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

How to save PrEP access — and even expand it

Why are Kaiser Permanente staff considering a strike?

Virginia high school admissions case could be legal follow

Thermo Fisher plant for manufacturing gene therapies to expand

hotspot

Does Medicare's free annual wellness visit do any good?

STAT Virtual Event: Putting AI to the Test

How Vertex's cystic fibrosis drug is changing patients' lives

Calls for Trump's election interference trial to be televised part of long debate

Lasker Awards 2023: Winners in biomedical research

Drug for rare kidney disease narrowly misses mark in clinical trial

hotspot

explore

focus

focus